Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN111518021B reveals a novel iodide-catalyzed oxidative cyclization using styrene and DMF, offering a cost-effective, metal-free route for high-purity pharmaceutical intermediates.
Patent CN103351291B details high-purity Phloretin production. Offers cost reduction and supply chain reliability for cosmetic and pharma industries.
Patent CN112898192B reveals a novel Pd-catalyzed route to N-acyl indoles using solid CO surrogates, offering safer scalable manufacturing for pharmaceutical intermediates.
Patent CN111100085A reveals a green deep eutectic solvent method for synthesizing benzoxazine derivatives, offering cost reduction in API manufacturing and scalable production.
Novel Pd-catalyzed defluoroalkynylation method for high-purity naphthofuran intermediates. Cost-effective route for pharmaceutical and material applications.
Patent CN113929569A reveals a mild, high-yield route for monofluoro iodoacetone compounds. Discover cost-effective manufacturing and scalable supply solutions for fluorinated intermediates.
Novel Pd-catalyzed bis-carbonylation route offers high yields and broad substrate scope for bioactive scaffolds, ensuring reliable supply chain stability.
Novel elemental sulfur-promoted synthesis method significantly reduces costs and improves safety for high-purity pharmaceutical intermediate manufacturing supply chains globally without heavy metals.
Novel Rh-catalyzed C-H activation for trifluoromethyl enaminones. High purity, scalable process for pharmaceutical intermediates. Reduces lead time for high-purity API intermediate manufacturing.
Patent CN113121462B reveals a metal-free route to 5-CF3 triazoles using diazo compounds. Offers cost reduction in API manufacturing and scalable supply chain solutions.
Novel visible light iron catalysis method for 4-arylbutyronitrile. Offers 100% atom economy and mild conditions for scalable pharmaceutical intermediate manufacturing.
Novel rhodium-catalyzed method for trifluoromethyl enaminones. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel metal-catalyzed cyclization method for indoline compounds. Offers high selectivity, scalable production, and cost-effective manufacturing for pharmaceutical intermediates.
Novel catalyst-free method for 3-selenocyanoindoles using elemental selenium. High yields, scalable process for pharmaceutical and agrochemical manufacturing.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply and cost reduction.
Patent CN113735778A reveals a novel Ag2O-promoted synthesis for 5-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and scalable production.
Patent CN110229187A enables mild alkyl phosphonate synthesis. Offers cost reduction in pharma intermediate manufacturing and reliable supply chain continuity.
Patent CN113121462B reveals a metal-free, azide-safe route for 5-trifluoromethyl-1,2,3-triazoles, offering cost reduction in API manufacturing and scalable supply.
Patent CN111620896A details a robust synthesis of AQDAB compounds using stable potassium trifluoroborates, offering significant cost reduction and supply chain reliability for fine chemical intermediates.
Novel organocatalytic route for high-purity axial chiral indole-naphthalenes. Cost-effective, scalable process for chiral catalyst precursors and pharmaceutical intermediates.